FAQ Library
FAQ Library published on
May 10, 2016
In this Managing Myeloma FAQ, Dr. Sagar Lonial discusses the best indicator of improved outcomes in multiple myeloma: SCR, CR, IFCR, or MCR.
FAQ Library published on
May 5, 2016
Join Paul Richardson, MD, in this Managing Myeloma FAQ as he describes true myeloma defining events and their impact on clinical practice.
FAQ Library published on
April 18, 2016
Join Paul Richardson, MD, in this Managing Myeloma FAQ as he describes how to address medication compliance and adherence in the outpatient setting to oral medicines that we use in myeloma.
FAQ Library published on
April 7, 2016
Join Paul Richardson, MD, in this Managing Myeloma FAQ as he briefly discusses the Revised International Staging System (R-ISS).
FAQ Library published on
March 15, 2016
Join Robert Orlowski, MD, PhD in this brief Managing Myeloma FAQ as he discusses why a myeloma patient who has previous history of bone lesions should have a bone study as part of their CR assessment.
FAQ Library published on
March 10, 2016
Join Dr. Sagar Lonial in this brief discussion regarding the emerging therapy classes for multiple myeloma.
FAQ Library published on
February 29, 2016
Join Dr. Jatin Shah as he explains when panobinostat should be used.
FAQ Library published on
February 11, 2016
Join Dr. Jatin Shah as he explains whether or not the amount of time one has to achieve treatment goals in the patient governs choice.
FAQ Library published on
January 19, 2016
Join Dr. Jatin Shah as he explains how the new diagnostic criteria will impact when to initiate therapy.
FAQ Library published on
January 14, 2016
Join Dr. Jatin Shah as he describes how patients with smoldering multiple myeloma will be impacted by the new diagnostic criteria.